Portal de investigação
Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Garcia, B
- Su, FH
- Dewachter, L
- Favory, R
- Khaldi, A
- Moiroux-Sahraoui, A
- Annoni, F
- Rocha-Oliveira, E
- Hubesch, G
- Njimi, H
- Vincent, JL
- Taccone, FS
- Creteur, J
- Herpain, A
Unidades de investigação
Abstract
Background Angiotensin II is one of the vasopressors available for use in septic shock. However, its effects on the septic myocardium remain unclear. The aim of the study was to compare the effects of angiotensin II and norepinephrine on cardiac function and myocardial oxygen consumption, inflammation and injury in experimental septic shock. Methods This randomized, open-label, controlled study was performed in 20 anesthetized and mechanically ventilated pigs. Septic shock was induced by fecal peritonitis in 16 animals, and four pigs served as shams. Resuscitation with fluids, antimicrobial therapy and abdominal drainage was initiated one hour after the onset of septic shock. Septic pigs were randomly allocated to receive one of the two drugs to maintain mean arterial pressure between 65 and 75 mmHg for 8 h. Results There were no differences in MAP, cardiac output, heart rate, fluid balance or tissue perfusion indices in the two treatment groups but myocardial oxygen consumption was greater in the norepinephrine-treated animals. Myocardial mRNA expression of interleukin-6, interleukin-6 receptor, interleukin-1 alpha, and interleukin-1 beta was higher in the norepinephrine than in the angiotensin II group. Conclusions In septic shock, angiotensin II administration is associated with a similar level of cardiovascular resuscitation and less myocardial oxygen consumption, and inflammation compared to norepinephrine.
Dados da publicação
- ISSN/ISSNe:
- 1466-609X, 1364-8535
- Tipo:
- Article
- Páginas:
- -
Critical Care BioMed Central Ltd.
Citações Recebidas na Web of Science: 4
Documentos
- Não há documentos
Filiações
Keywords
- Septic shock; Septic cardiomyopathy; Vasopressors; Inflammation; Renin-angiotensin system
Financiamento
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Comparação de escala de qualidade de vida na insuficiência cardíaca com fração de ejeção reduzida quando realizada no domicílio ou na consulta hospitalar.
Investigador Principal: Francisco Aguiar Vasques Novoa Faria
Estudo Observacional Académico (QualidadeIC) . 2021
Myocardial Edema: Pathophysiological Basis and Implications for Cardiac Disease
Investigador Principal: Roberto Liberal Fernandes Roncon Albuquerque
Estudo Clínico Académico . 2021
Identification of the microRNA expression signature in Human Septic Cardiomyopathy
Investigador Principal: Roberto Liberal Fernandes Roncon Albuquerque
Estudo Clínico Académico . 2021
Bleeding and Thrombotic complications in COVID-19-associated ARDS requiring ECMO
Investigador Principal: Roberto Liberal Fernandes Roncon Albuquerque
Estudo Clínico Académico . 2022
Renal warm ischemia in organ donors after circulatory death
Investigador Principal: Roberto Liberal Fernandes Roncon Albuquerque
Estudo Clínico Académico . 2020
Citar a publicação
Garcia B,Su FH,Dewachter L,Favory R,Khaldi A,Moiroux A,Annoni F,Vasques F,Rocha E,Roncon R,Hubesch G,Njimi H,Vincent JL,Taccone FS,Creteur J,Herpain A. Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock. Crit. Care. 2022. 26. (1):281. IF:15,100. (1).
